About Oculina

Oculinea is a preclinical stage drug-device therapeutics company spun out of University of California, San Francisco (UCSF) focused on developing transformational drug delivery implants for vision care. Oculinea developed a proprietary MIDS platform keeping the patients and ophthalmologists in mind for minimally invasive office-based procedures for intraocular sustained delivery of both small molecule and biologic therapeutics. MIDS is set to transform the treatment paradigm for chronic ocular conditions like glaucoma, macular degeneration, and diabetic retinopathy.